Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Clinical trial NCT07483983 · RECRUITING

Trial details

NCT number: NCT07483983
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic/Locally Advanced Non-Small-Cell Lung Cancer Metastatic/Locally Pancreatic Ductal Adenocarcinoma

Start date: 2026-03-25
Primary completion: 2027-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.